Researchers from Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB and partners have developed a groundbreaking approach to identify pathogens in sepsis patients, potentially reducing mortality rates and improving treatment outcomes. The team has been awarded the 2024 Stifterverband Science Prize for their innovative work.
Researchers at Moffitt Cancer Center have developed a novel method for the scalable synthesis of withanolides, a class of naturally occurring compounds with significant potential in cancer treatment. This groundbreaking approach, published in Science Advances [1], could revolutionise cancer research by providing a reliable and efficient means of producing these vital compounds in large quantities.
A team of engineers at the California Institute of Technology (Caltech) has developed a groundbreaking microscopy method that promises to revolutionise biomedical imaging, digital pathology, and drug screening. The new technique, called Angular Ptychographic Imaging with Closed-form method (APIC), builds upon and surpasses the capabilities of its predecessor, Fourier ptychographic microscopy (FPM).
Scientists at King’s College London have developed a rapid method for creating cyclic peptides, potentially accelerating the production of new antibiotics to combat antimicrobial resistance (AMR). The research, published in the Journal of the American Chemical Society [1], demonstrates a technique that reduces synthesis time from hours or days to mere minutes.
UK-based toxicology specialist Contract Research Organisation (CRO) Gentronix has been awarded the prestigious King’s Award for Enterprise for 2024 in recognition of its remarkable international trade performance. The Alderley Park-based firm has demonstrated exceptional growth in overseas earnings, with a 239% increase over the past three years.
UK-based biotechnology firm Nuclera has been awarded two Innovate UK grants totalling £1.14 million to further develop its eProtein Discovery system. The funding comprises a £790,000 flexible, agile, scalable, and sustainable technologies (FASST) grant and a £350,000 Engineering Biology grant.
The Celonic Group, a Swiss-based contract development and manufacturing organisation (CDMO) specialising in quality biologics, has inaugurated its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland. This expansion aims to support pharmaceutical companies in developing and optimising processes using advanced bioprocessing technologies.
SGS, a leading provider of biopharmaceutical testing services, has announced the expansion of its laboratory in Birsfelden, Switzerland, to include stability studies. This addition to the facility’s service portfolio aims to meet the growing demand for comprehensive and reliable stability testing in the biopharmaceutical industry.
Icosagen, a contract research, development, and manufacturing organisation (CRDMO) specialising in innovative antibody research and production, has announced a strategic partnership with Lead Discovery Center GmbH (LDC), a translational drug discovery organisation. The collaboration aims to discover monoclonal antibody portfolios targeting therapeutically relevant proteins, including a pivotal G-protein coupled receptor (GPCR), which are often challenging […]
Leading contract development and manufacturing organisation (CDMO) Vetter has announced significant expansion plans in both the United States and Germany, aiming to meet the growing demand for outsourced development and manufacturing of injectable medications.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
